What is the current consensus on whether motion sickness patches behind the ear cause blurry vision in twelve year olds based on recent pediatric guidelines?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the current consensus on whether motion sickness patches behind the ear cause blurry vision in twelve year olds based on recent pediatric guidelines?
3 real searches · 1 real-search pass
2026 pediatric guidance scopolamine transdermal patch children under 18 blurred vision motion sickness FDA labelGoogle ↗
OBSERVEDConsequence
AAP pediatric motion sickness scopolamine patch children blurred vision guidelineGoogle ↗
OBSERVEDInstruction
CDC Yellow Book motion sickness scopolamine children pediatric adverse effects blurred visionGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
2026 pediatric guidance scopolamine transdermal patch children under 18 blurred vision motion sickness FDA label Google ↗
AAP pediatric motion sickness scopolamine patch children blurred vision guideline Google ↗
CDC Yellow Book motion sickness scopolamine children pediatric adverse effects blurred vision Google ↗
- Motion Sickness · cdc.gov
- label · accessdata.fda.gov
- Car Sickness · healthychildren.org
- FDA adds warning about serious risk of heat-related complications with antinausea patch · fda.gov
- DailyMed - SCOPOLAMINE TRANSDERMAL SYSTEM patch, extended release · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 · dailymed.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 pediatric guidance scopolamine transdermal patch children under 18 blurred vision motion sickness FDA label OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
AAP pediatric motion sickness scopolamine patch children blurred vision guideline OBSERVED | Google ↗ AI Mode ↗ | — | Instruction | — | — | 1x of 1 | |
CDC Yellow Book motion sickness scopolamine children pediatric adverse effects blurred vision OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |